In summary, as detailed by our data, heightened expression of MCP-1, MCP-3, IL-8, and/or IP-10 demonstrates how an overzealous monocyte/macrophage driven immune response can contribute to ARDS development in COVID-19. This evidence concerns the gene CXCL8 and acute respiratory distress syndrome.